Showing results (211-220 of 232) with videos related to
Sort By:
Pageof 24
American Journal of Hematology|April 7, 2017
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J Castillo, Artur Jurczyszyn, Lucie Brozova, et al.Nature Communications|July 23, 2015
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patientsElad Ziv, Eric Dean, Donglei Hu, et al.International Journal of Cancer|July 29, 2014
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere lengthDaniele Campa, Alessandro Martino, Judit Varkonyi, et al.Leukemia Research|May 28, 2014
Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective--a report by Polish Myeloma Study GroupAdam Walter-Croneck, Norbert Grzasko, Maria Soroka-Wojtaszko, et al.European Journal of Human Genetics : EJHG|November 30, 2021
A polygenic risk score for multiple myeloma risk predictionFederico Canzian, Chiara Piredda, Angelica Macauda, et al.British Journal of Haematology|March 16, 2021
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerationsLaura Rosiñol, Meral Beksac, Elena Zamagni, et al.Leukemia|December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJ Laubach, L Garderet, A Mahindra, et al.Leukemia & Lymphoma|April 21, 2020
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patientsSarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, et al.Future Oncology (London, England)|September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.The New England Journal of Medicine|December 12, 2023
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple MyelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.Pageof 24